Biomaterials legislation
This article was originally published in The Gray Sheet
Executive Summary
"Biomaterials Access Assurance Act" becomes law Aug. 13 following President Clinton's signing of the bill (HR 872). Both the House and Senate passed the bill, which provides liability protections for suppliers of raw materials used in implantable medical devices, the week of July 27 ("The Gray Sheet" Aug. 3, p. 7)
You may also be interested in...
GHTF Study Group One To Consider Issue Of Biomaterials Testing
Harmonizing biomaterials testing worldwide could be achieved through a global master file database, FDA Office of Device Evaluation Deputy Director Kimber Richter, MD, suggested to Study Group One July 1 at a session of the Global Harmonization Task Force's annual meeting in Bethesda, Maryland.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.